Shabeeha Rana(@ShabeehaKhizer) 's Twitter Profile Photo

Great talk on Follicular lymphoma by Dr JW Friedberg: time to really think of “cure” in Follicular Lymphoma: bring on the head to head antibodies to clinical trails to give us an answer.

Great talk on Follicular lymphoma by Dr JW Friedberg: time to really think of “cure” in Follicular Lymphoma: bring on the head to head antibodies to clinical trails to give us an answer. #ICML2023 #follicularlymphoma #bispecificantibodies
account_circle
Warwick Cancer Clinical Trials(@CancerWarwick) 's Twitter Profile Photo

highlights conditions affecting < 1 in 2000 people. Collectively, these diseases are not rare, affecting 1 in 17 people in the UK. Almost 1 in 5 cancers fall into this category. We support research into , , , &

account_circle
Warwick Cancer Clinical Trials(@CancerWarwick) 's Twitter Profile Photo

Welcome Chenise, our new Cancer Research Nurse! Joining us from the @nhsswft, she brings 8+ years of Haematology experience and will be leading on our upcoming and trials.

Welcome Chenise, our new Cancer Research Nurse! Joining us from the #AylesfordUnit @nhsswft, she brings 8+ years of Haematology experience and will be leading on our upcoming #follicularlymphoma and #DLBCL trials. #bepartofresearch
account_circle
Oncology Data Advisor(@OncData) 's Twitter Profile Photo

Did you hear that / has received approval for ( )? Hear about the trial and insights on the approval from Alankrita Taneja, MD in this article, and comment your thoughts below!

oncdata.com/news/zanubruti…

Did you hear that #zanubrutinib/#obinutuzumab has received #accelerated #FDA approval for #FollicularLymphoma (#FL)? Hear about the trial and insights on the approval from @TanejaMD in this article, and comment your thoughts below!

oncdata.com/news/zanubruti…

#lymsm
account_circle
Warwick Cancer Clinical Trials(@CancerWarwick) 's Twitter Profile Photo

We're open to ! @nhsswft patients with previously untreated now have the opportunity to access PET-guided response-adapted therapy. Body scans will monitor how participants respond to treatment and help choose the best balance of future treatments.

We're open to #PETReA! @nhsswft patients with previously untreated #FollicularLymphoma now have the opportunity to access PET-guided response-adapted therapy. Body scans will monitor how participants respond to treatment and help choose the best balance of future treatments.
account_circle
Haematologica(@Haematologica) 's Twitter Profile Photo

Grade 3B follicular lymphoma: read here the results of the first large international study on prognosis, outcomes and relapse patterns of this rare subtype in the rituximab era.
haematologica.org/article/view/h…

Grade 3B follicular lymphoma: read here the results of the first large international study on prognosis, outcomes and relapse patterns of this rare #FollicularLymphoma subtype in the rituximab era.
haematologica.org/article/view/h…
account_circle
HemaSphere Journal (IF = 9.1)(@Hemasphere_EHA) 's Twitter Profile Photo

Identification of risk factors of progression in low-tumor burden is initially managed by watch&wait, but the importance of extranodal involvement & quantitative PET-CT parameters exists 👉bit.ly/3Hy5PQZ

account_circle
NIAID News(@NIAIDNews) 's Twitter Profile Photo

and scientists identified distinguishing features and patterns in the tumors and lymph-node tissue of people with who relapsed within 24 months. The findings could help predict early relapse and inform treatment decisions. doi.org/10.1016/j.ccel…

#NIAID and #NCI scientists identified distinguishing features and patterns in the tumors and lymph-node tissue of people with #FollicularLymphoma who relapsed within 24 months. The findings could help predict early relapse and inform treatment decisions. doi.org/10.1016/j.ccel…
account_circle